Showing results (211-220 of 246) with videos related to
Sort By:
Pageof 25
Trials|July 1, 2020
Stress ulcer prophylaxis versus placebo-a blinded randomized control trial to evaluate the safety of two strategies in critically ill infants with congenital heart disease (SUPPRESS-CHD)Kimberly I Mills, Ben D Albert, Lori J Bechard, et al.Neurotoxicity Research|June 22, 2006
Oxidative neuropathology and putative chemical entities for Alzheimer's disease: neuroprotective effects of salen-manganese catalytic anti-oxidantsH T Rupniak, K A Joy, C Atkin, et al.Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|January 19, 2024
Stress Ulcer Prophylaxis Versus Placebo-A Blinded Pilot Randomized Controlled Trial to Evaluate the Safety of Two Strategies in Critically Ill Infants With Congenital Heart DiseaseKimberly I Mills, Ben D Albert, Lori J Bechard, et al.Oncotarget|February 1, 2018
Polycomb protein RING1A limits hematopoietic differentiation in myelodysplastic syndromesAnna Palau, Anne-Kathrin Garz, Jeannine Diesch, et al.Bioorganic & Medicinal Chemistry Letters|May 30, 2001
6,6'-Bis(2-hydroxyphenyl)-2,2'-bipyridine manganese(III) complexes: a novel series of superoxide dismutase and catalase mimeticsG M Giblin, P C Box, I B Campbell, et al.Haematologica|March 30, 2013
HOXA/PBX3 knockdown impairs growth and sensitizes cytogenetically normal acute myeloid leukemia cells to chemotherapyGlenda J Dickson, Fabio G Liberante, Laura M Kettyle, et al.Neurobiology of Disease|February 13, 2026
Differences in white matter detected by ex vivo 9.4 T MRI are associated with axonal changes in the R6/1 model of Huntington's diseaseC Casella, B Kelly, A Murillo, et al.Proceedings of the National Academy of Sciences of the United States of America|November 15, 2007
RARalpha-PLZF overcomes PLZF-mediated repression of CRABPI, contributing to retinoid resistance in t(11;17) acute promyelocytic leukemiaFabien Guidez, Sarah Parks, Henna Wong, et al.Blood|August 18, 2005
Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemiaRosemary E Gale, Robert Hills, Arnold R Pizzey, et al.Journal of Medical Virology|November 20, 2025
Preclinical Screening Platform Identifies Azatadine-Dimaleate as a Potent Repurposed Therapeutic Against SARS-CoV-2 InfectionAhlam Ali, David Courtney, Lindsay Broadbent, et al.Pageof 25